chr6-29941649-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The variant allele was found at a frequency of 0.132 in 151,432 control chromosomes in the GnomAD database, including 548 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.13 ( 548 hom., cov: 35)

Consequence

HCG4P5
intragenic

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0680

Publications

2 publications found
Variant links:
Genes affected
HCG4P5 (HGNC:22925): (HLA complex group 4 pseudogene 5)
HLA-A (HGNC:4931): (major histocompatibility complex, class I, A) HLA-A belongs to the HLA class I heavy chain paralogues. This class I molecule is a heterodimer consisting of a heavy chain and a light chain (beta-2 microglobulin). The heavy chain is anchored in the membrane. Class I molecules play a central role in the immune system by presenting peptides derived from the endoplasmic reticulum lumen so that they can be recognized by cytotoxic T cells. They are expressed in nearly all cells. The heavy chain is approximately 45 kDa and its gene contains 8 exons. Exon 1 encodes the leader peptide, exons 2 and 3 encode the alpha1 and alpha2 domains, which both bind the peptide, exon 4 encodes the alpha3 domain, exon 5 encodes the transmembrane region, and exons 6 and 7 encode the cytoplasmic tail. Polymorphisms within exon 2 and exon 3 are responsible for the peptide binding specificity of each class one molecule. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. More than 6000 HLA-A alleles have been described. The HLA system plays an important role in the occurrence and outcome of infectious diseases, including those caused by the malaria parasite, the human immunodeficiency virus (HIV), and the severe acute respiratory syndrome coronavirus (SARS-CoV). The structural spike and the nucleocapsid proteins of the novel coronavirus SARS-CoV-2, which causes coronavirus disease 2019 (COVID-19), are reported to contain multiple Class I epitopes with predicted HLA restrictions. Individual HLA genetic variation may help explain different immune responses to a virus across a population.[provided by RefSeq, Aug 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.175 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000396634.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

There are no transcript annotations for this variant.

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HLA-A
ENST00000396634.5
TSL:6
c.-281-317T>C
intron
N/AENSP00000379873.1
POLR1HASP
ENST00000849679.1
n.66-13103A>G
intron
N/A
POLR1HASP
ENST00000849682.1
n.751-13103A>G
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.132
AC:
20000
AN:
151318
Hom.:
543
Cov.:
35
show subpopulations
Gnomad AFR
AF:
0.178
Gnomad AMI
AF:
0.103
Gnomad AMR
AF:
0.147
Gnomad ASJ
AF:
0.128
Gnomad EAS
AF:
0.123
Gnomad SAS
AF:
0.164
Gnomad FIN
AF:
0.0891
Gnomad MID
AF:
0.146
Gnomad NFE
AF:
0.106
Gnomad OTH
AF:
0.145
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.132
AC:
20047
AN:
151432
Hom.:
548
Cov.:
35
AF XY:
0.132
AC XY:
9785
AN XY:
74030
show subpopulations
African (AFR)
AF:
0.179
AC:
7332
AN:
41070
American (AMR)
AF:
0.147
AC:
2237
AN:
15228
Ashkenazi Jewish (ASJ)
AF:
0.128
AC:
443
AN:
3454
East Asian (EAS)
AF:
0.124
AC:
635
AN:
5140
South Asian (SAS)
AF:
0.165
AC:
792
AN:
4786
European-Finnish (FIN)
AF:
0.0891
AC:
943
AN:
10588
Middle Eastern (MID)
AF:
0.151
AC:
44
AN:
292
European-Non Finnish (NFE)
AF:
0.106
AC:
7224
AN:
67862
Other (OTH)
AF:
0.144
AC:
303
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.436
Heterozygous variant carriers
0
611
1221
1832
2442
3053
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
236
472
708
944
1180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.116
Hom.:
50
Asia WGS
AF:
0.133
AC:
461
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
4.6
DANN
Benign
0.46
PhyloP100
0.068
PromoterAI
0.027
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9260090; hg19: chr6-29909426; API